References
- Bryant, A.E., Dreifuss, F.E., 1996. Valproic acid hepatic fatalities. III. U.S. experience since 1986, Neurology. 46, 465-469. https://doi.org/10.1212/WNL.46.2.465
- Cheng, H., Liu, Z., Blum, W., Byrd, J.C., Klisovic, R., Grever, M.R., Marcucci, G., Chan, K.K., 2007. Quantification of valproic acid and its metabolite 2-propyl-4-pentenoic acid in human plasma using HPLC-MS/MS, J. Chromatogr. B., 850, 206-212. https://doi.org/10.1016/j.jchromb.2006.11.027
- Fisher, E., Wittfohy, W., Nau, H., 1992. Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography/mass spectrometry, Biomed. Chromatogr. 6, 24-9. https://doi.org/10.1002/bmc.1130060108
- Gerber, N., Dickinson, R.G., Harland, R.K., Lynn, R., Houghton, D. L., Antonias, J. I., Schimschock, J.C., 1979. Reye-like syndrome associated with valproic acid therapy, J. Pediatr. 95, 142-144. https://doi.org/10.1016/S0022-3476(79)80110-9
- Kassahun, K., Farrell, K., Abott, F.S., 1991. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans, Drug. Metab. Dispos. 525-535.
-
Leis, H.J., Windischhofer, W., Rechberger, G.N., Fauler, G., 2003. Synthesis of [
$^{18}O$ ] valproic acid and its use as an internal standard for the quantitative measurement by gas chromatographyelectron ionization mass spectrometry, J. Chromatogr. B. 784, 69-75. https://doi.org/10.1016/S1570-0232(02)00755-9 - Loscher, W., Nau, H., Wahnschaffe, U., Hönack , D., Rundfeldt, C., Wittfoht, W., Bojic U., 1993. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. II. Influence of phenobarbital comedication, Epilepsy Res. 15, 113-131. https://doi.org/10.1016/0920-1211(93)90092-L
- Murakami, K., Sugimoto, T., Nishida, N., Kobayashi , Y., Kuhara, T., Matsumoto, I., 1992. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy, Brain Dev. 14, 178-181. https://doi.org/10.1016/S0387-7604(12)80261-0
- Perucca, E., 2002. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience, CNS Drugs, 16, 695-714. https://doi.org/10.2165/00023210-200216100-00004
- Sugimoto, T., Nishida, N., Yasuhara, A., Ono A., Sakane, Y., Matsumura, T., 1983. Reye-like syndrome associated with valproic acid, Brain Dev. 5, 334-337. https://doi.org/10.1016/S0387-7604(83)80029-1
- Yu, D., Gordon, J.D., Zheng, J., Panesar, S.K., Riggs, K.W., Rurak D.W., Abott, F.S., 1995. Determination of valproic acid and its metabolites using gas chromatography with mass selective detection: application to serum and urine samples from sheep, J. Chromatogr. B. 666, 269-281. https://doi.org/10.1016/0378-4347(94)00585-S
- Zafrani, E.S., Berthelot, P., 1982. Sodium valproate in the induction of unusual hepatotoxicity, Hepatology. 2, 648-649. https://doi.org/10.1002/hep.1840020520
- Zimmerman, H.J., Ishak, K.G., 1982. Valproate-induced hepatic injury: analyses of 23 fatal cases, Hepatology. 2, 591-597. https://doi.org/10.1002/hep.1840020513